Biotech

March 14, 2023
Celmatix and Global Collaborators Release Findings from Largest Genetic Study to Date on Endometriosis
March 14, 2023
Biotech Startup theblood Raises Close to €1M in Pre-Seed Funding for Its Menstrual Blood Testing Solution and Biomarker Research
March 3, 2023
Cedars-Sinai Study Could Help Pave the Way to Early Diagnosis and Treatment for Pregnancy-Related Mood Disorders
February 28, 2023
Consumer Biotech Company Tally Health Launches a New Platform Aimed at Extending Longevity
February 21, 2023
Gameto Licenses Wyss Institute’s Technology for Growing Human Ovaries from Harvard University
February 8, 2023
Biotech Company HBM Alpha Therapeutics Adds Seed Funding to Advance Next-Gen Therapies for PCOS and Congenital Adrenal Hyperplasia
January 27, 2023
New Data Suggests Daré Bioscience’s Intravaginal Ring Can Help Manage Vasomotor and Vaginal Menopause Symptoms
January 23, 2023
Male Contraception Initiative Invests $800K in Eppin Pharma to Support Clinical Trials for a Non-Hormonal Contraceptive
January 6, 2023
Biotech: Second Novel PCOS Drug Target from Celmatix-Evotec Alliance Progresses into Hit-Identification
October 5, 2022
Xosomix Receives a NIH Phase I Grant to Develop a Diagnostic Biomarker for Endometriosis
September 15, 2022
Biotech Company Gameto Adds $17M in Funding to Develop Therapeutics for Diseases in the Female Reproductive System
August 22, 2022
ART: Japanese Fertility Startup Dioseve Raises $3M to Re-engineer Oocyte Development
August 11, 2022
Nanopath Raises $10M in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women’s Health
June 14, 2022
Organon Signs a Licensing Deal with Henlius for Biosimilars Targeting Osteoporosis and Breast Cancer
May 20, 2022
Women’s Health Biotech Company Oviva Raises $11.5M in Seed Funding to Address Ovarian Aging
May 18, 2022
Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications
May 16, 2022
Celmatix Reaches a Key Preclinical Milestone in Its Premature Menopause Prevention Drug Program
February 21, 2022
Renegade.bio and Metabolomic Diagnostics Partner to Develop a Novel Preeclampsia Risk Screening Test
January 24, 2022
Biotech Company Amyris Gets Serious about the Menopause Market with the Acquisition of Menolabs
January 23, 2022
Biotech: All Eyes on Ovarian Health and Biology
January 18, 2022
Celmatix, Evotec & Bayer Just Hit Another Milestone in Their Quest to Develop a First-in-Class Drug for PCOS
January 13, 2022
BioInnovation Institute Receives a Grant from the Gates Foundation to Launch a New Initiative Focused on Women’s Health
January 10, 2022
Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells
January 10, 2022
New Study: Mirvie Can Predict Pregnancy Complications Months Before They Happen